Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q0OD
|
|||
| Former ID |
DNCL001580
|
|||
| Drug Name |
Secukinumab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Approved | [1] | |
| Alopecia [ICD-11: ED70] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Atopic dermatitis [ICD-11: EA80; ICD-10: L20] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Dry eye disease [ICD-11: 9E1Z] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Multiple sclerosis [ICD-11: 8A40] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Psoriatic arthritis [ICD-11: FA21] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Type-1 diabetes [ICD-11: 5A10] | Phase 2 | [2], [3], [4], [5], [6], [7], [8], [9], [10], [11] | ||
| Company |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
|
|||
| SuperDrug ATC ID |
L04AC10
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
| REF 2 | ClinicalTrials.gov (NCT01359943) Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate | |||
| REF 3 | ClinicalTrials.gov (NCT01250171) The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients | |||
| REF 4 | ClinicalTrials.gov (NCT01874340) Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis | |||
| REF 5 | ClinicalTrials.gov (NCT01426789) A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients | |||
| REF 6 | ClinicalTrials.gov (NCT02854163) Effect of Secukinumab in the Treatment of Psoriatic Arthritis | |||
| REF 7 | ClinicalTrials.gov (NCT02044848) Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus | |||
| REF 8 | ClinicalTrials.gov (NCT02599129) A Study of Secukinumab for the Treatment of Alopecia Areata | |||
| REF 9 | ClinicalTrials.gov (NCT02594098) Secukinumab for Treatment of Atopic Dermatitis | |||
| REF 10 | ClinicalTrials.gov (NCT03041038) The Efficacy and Safety of Secukinumab in Patients With Ichthyoses | |||
| REF 11 | ClinicalTrials.gov (NCT03131570) Safety and Efficacy of Secukinumab in Mild Psoriasis | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.